OSR Health (OSRHW) Goodwill & Intangibles (2023 - 2026)
OSR Health (OSRHW) posted Goodwill & Intangibles of $145.4 million for Q1 2026, down 13.16% sequentially from $167.4 million in Q4 2025, and down 14.77% YoY from $170.6 million in Q1 2025.
OSR Health (OSRHW) Goodwill & Intangibles (2023 - 2026) Analysis & Trends
OSR Health has reported Goodwill & Intangibles for 4 years, with the latest figure at $145.4 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 14.77% year-over-year to $145.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.4 million (down 14.77% YoY) and the FY2025 annual result came in at $167.4 million, down 2.9% from the prior year.
- Goodwill & Intangibles fell to $145.4 million in Q1 2026 per OSRHW's latest filing, from $167.4 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $182.0 million in Q2 2025 and troughed at $26.6 million in Q1 2024.
- A 4-year average of $111.9 million and a median of $156.4 million in 2025 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles surged 584.61% in 2025, then decreased 14.77% in 2026.
- Over 4 years, Goodwill & Intangibles stood at $27.8 million in 2023, then jumped by 520.96% to $172.4 million in 2024, then fell by 2.9% to $167.4 million in 2025, then retreated by 13.16% to $145.4 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $145.4 million, $167.4 million, and $173.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145.37 Mn |
| Dec 31, 2025 | 167.41 Mn |
| Sep 30, 2025 | 173.68 Mn |
| Jun 30, 2025 | 181.98 Mn |
| Mar 31, 2025 | 170.57 Mn |
| Dec 31, 2024 | 172.41 Mn |
| Sep 30, 2024 | 26.58 Mn |
| Jun 30, 2024 | 26.58 Mn |
| Mar 31, 2024 | 26.58 Mn |
| Dec 31, 2023 | 27.77 Mn |